Produkty 601-54-7

CAS 601-54-7 występuje w naszej ofercie pod nazwami: 3-Keto Cholesterol, >95% (HPLC), 5–Cholesten–3–one, 3-Keto cholesterol, 5-Cholesten-3-one, >95%, >95%, 5-CHOLESTEN-3-ONE, >95%. Oferty producentów: TRC, GLPBio, Biosynth, Chemat, Fluorochem. Dostępne opakowania: 100mg, 25mg, 5mg, 1g, 250mg, 50mg, 100000mg, 500mg.

3-Keto Cholesterol, >95% (HPLC)
TRC
  • opakowanie: 100mg, 25mg, 5mg
  • Warianty: 3
Zobacz produkt
5–Cholesten–3–one
GLPBio
  • opakowanie: 100mg, 1g, 250mg
  • Warianty: 3
od 817,02
Zobacz produkt
3-Keto cholesterol
Biosynth
  • opakowanie: 50mg, 100mg, 250mg, 100000mg
  • Warianty: 5
Zobacz produkt
5-Cholesten-3-one, >95%, >95%
Chemat
  • opakowanie: 100mg, 250mg, 5g, 1g
  • Warianty: 4
od 587,60
Zobacz produkt
5-CHOLESTEN-3-ONE, >95%
Fluorochem
  • opakowanie: 250mg
  • Warianty: 1
od 1138,16
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one (CAS 601-54-7) to związek chemiczny o wzorze sumarycznym C27H44O i masie molowej 384.6 g/mol. Nazwa systematyczna IUPAC: (8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one. InChIKey: GGCLNOIGPMGLDB-GYKMGIIDSA-N.

Dane identyfikacyjne
Wzór sumarycznyC27H44O
Masa molowa384.6 g/mol
Nazwa IUPAC(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
InChIKeyGGCLNOIGPMGLDB-GYKMGIIDSA-N
SMILESC[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CCC(=O)C4)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 5-Cholesten-3-one, 3-ketocholesterol, 3-Keto Cholesterol, 3-Oxocholest-5-ene, Cholestenone (delta 5), 5-Cholestenone, .delta.(sup5)-Cholestenone, delta(sup 5)-Cholestenone, 5-cholesten-3-on, Delta(5)-cholestenone
Izomery (ten sam wzór sumaryczny)
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-7,7,7-trideuterio-6-(trideuteriomethyl)hept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O
(3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O
(1S)-3-[(E)-2-[(1R,3aR,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol C27H44O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O
(3S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O
(1S)-3-[(E)-2-[(1R,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol C27H44O
(1S,3E)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O
(1S)-3-[(Z)-2-[(1R,3aR,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol C27H44O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O
(1S,5E)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohex-3-en-1-ol C27H44O